A
Alexander Santillo
Researcher at Lund University
Publications - 52
Citations - 1639
Alexander Santillo is an academic researcher from Lund University. The author has contributed to research in topics: Frontotemporal dementia & Dementia. The author has an hindex of 16, co-authored 38 publications receiving 1068 citations. Previous affiliations of Alexander Santillo include Uppsala University & Stockholm County Council.
Papers
More filters
Journal ArticleDOI
Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders
Rik Ossenkoppele,Rik Ossenkoppele,Gil D. Rabinovici,Ruben Smith,Hanna Cho,Michael Schöll,Michael Schöll,Olof Strandberg,Sebastian Palmqvist,Niklas Mattsson,Shorena Janelidze,Alexander Santillo,Tomas Ohlsson,Jonas Jögi,Richard M. Tsai,Renaud La Joie,Joel H. Kramer,Adam L. Boxer,Maria Luisa Gorno-Tempini,Bruce L. Miller,Jae Y. Choi,Young Hoon Ryu,Chul Hyoung Lyoo,Oskar Hansson +23 more
TL;DR: Among patients with established diagnoses at a memory disorder clinic, [18F]flortaucipir PET was able to discriminate AD from other neurodegenerative diseases, and the accuracy and potential utility of this test in patient care require further research in clinically more representative populations.
Journal ArticleDOI
In vivo amyloid imaging with PET in frontotemporal dementia.
Henry Engler,Alexander Santillo,Shu Xia Wang,Maria Lindau,Irina Savitcheva,Agneta Nordberg,Agneta Nordberg,Lars Lannfelt,Bengt Langstrom,Bengt Langstrom,Lena Kilander +10 more
TL;DR: PIB could potentially aid in differentiating between FTD and AD, and eight FTD patients showed significantly lower PIB retention compared to AD in frontal, parietal, temporal, temporal and occipital cortices.
Journal ArticleDOI
Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
Shorena Janelidze,Joakim Hertze,Henrik Zetterberg,Henrik Zetterberg,Maria Landqvist Waldö,Alexander Santillo,Kaj Blennow,Oskar Hansson +7 more
TL;DR: Widespread implementation of cerebrospinal fluid biomarkers of Alzheimer's disease in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias.
Journal ArticleDOI
A multicentre validation study of the diagnostic value of plasma neurofilament light.
Nicholas J. Ashton,Shorena Janelidze,Ahmad Al Khleifat,Antoine Leuzy,Emma L. van der Ende,Thomas K. Karikari,Andrea Lessa Benedet,Andrea Lessa Benedet,Tharick A. Pascoal,Tharick A. Pascoal,A. Lleo,Lucilla Parnetti,Daniela Galimberti,Laura Bonanni,Andrea Pilotto,Alessandro Padovani,Jan Lycke,Jan Lycke,Lenka Novakova,Lenka Novakova,Markus Axelsson,Markus Axelsson,Latha Velayudhan,Latha Velayudhan,Gil D. Rabinovici,Bruce L. Miller,Carmine M. Pariante,Naghmeh Nikkheslat,Susan M. Resnick,Madhav Thambisetty,Michael Schöll,Michael Schöll,Gorka Fernández-Eulate,Francisco Javier Gil-Bea,Adolfo López de Munain,Ammar Al-Chalabi,Ammar Al-Chalabi,Pedro Rosa-Neto,Pedro Rosa-Neto,Andre Strydom,Andre Strydom,Per Svenningsson,Per Svenningsson,Erik Stomrud,Alexander Santillo,Dag Aarsland,Dag Aarsland,Dag Aarsland,John C. van Swieten,Sebastian Palmqvist,Henrik Zetterberg,Kaj Blennow,Kaj Blennow,Abdul Hye,Abdul Hye,Abdul Hye,Oskar Hansson +56 more
TL;DR: In this article, increased cerebrospinal fluid neurofilament light (NfL) is used as a marker of neurodegeneration in 13 neuro-degenerative disorders, Down syndrome, depression and cognitively unimpaired controls from two multicenter cohorts.
Journal ArticleDOI
Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders
Simon Ducharme,Annemiek Dols,Robert Laforce,Emma Devenney,Fiona Kumfor,Jan Van den Stock,Caroline Dallaire-Théroux,Harro Seelaar,Flora Gossink,Everard G. B. Vijverberg,Edward D. Huey,Mathieu Vandenbulcke,Mario Masellis,Calvin Trieu,Chiadi U. Onyike,Paulo Caramelli,Leonardo Cruz de Souza,Alexander Santillo,Maria Landqvist Waldö,Ramon Landin-Romero,Olivier Piguet,Wendy Kelso,Dhamidhu Eratne,Dennis Velakoulis,Manabu Ikeda,David C. Perry,Peter Pressman,Bradley F. Boeve,Rik Vandenberghe,Mario F. Mendez,Carole Azuar,Richard Levy,Isabelle Le Ber,Sandra Baez,Alan J. Lerner,Ratnavalli Ellajosyula,Florence Pasquier,Daniela Galimberti,Elio Scarpini,John C. van Swieten,Michael Hornberger,Howard J. Rosen,John R. Hodges,Janine Diehl-Schmid,Yolande A.L. Pijnenburg +44 more
TL;DR: The goal of the present paper was to review the existing literature on the diagnosis of bvFTD and its differential diagnosis with primary psychiatric disorders to provide consensus recommendations on the clinical assessment and clarify the role of 18F-fluorodeoxyglucose PET for the exclusion of b vFTD.